COVID-19 and renin angiotensin aldosterone system (RAAS)
PDF (Español)

How to Cite

García DL. COVID-19 and renin angiotensin aldosterone system (RAAS). Rev. Colomb. Nefrol. [Internet]. 2020 Apr. 15 [cited 2024 Jul. 16];7(Supl.2). Available from:
PDF (Español)


China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. Epub ahead of print. Available from:

Bavishi Ch, Maddox T, Messerli F. Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers. JAMA Cardiology. Published online April 3, 2020 Available from:

Soro-Paavonen A1, Gordin D, ForsblomC, Rosengard-Barlund M, Waden J, Thorn L, SandholmN, Thomas MC, Groop PH; FinnDiane Study Group.Circulating ECA2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens. 2012;30(2):375-83. Available from:

Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364-74. Available from:

Dong Chen, Xiaokun Li, Qifa Song et al. Hypokalemia and Clinical Implications in Patients with Coronavirus Disease 2019 (COVID19). medRxiv preprint. Available from:

Batlle D, Wysock iJ, Satchell K. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci (Lond). 2020;134(5):543-5. Available from:

European Society of Cardiology. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. Published March 13, 2020. Consultada en abril 10, 2020.

American Heart Association. HFSA/ACC/AHA statement addresses concernsre: usingRAAS antagonistsin COVID-19. Consultada abril 10, 2020

No national or foreign publication may partially or totally reproduce or translate Revista Colombiana de Nefrología articles or abstracts without prior written permission from the journal’s Editorial Board.




Download data is not yet available.